Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs

Wegovy-maker Novo Nordisk's CEO Mike Doustdar will face pressure on ​Monday to set out his strategy for competing with US rival Eli Lilly and how he plans to boost the company's growth beyond ‌the blo...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。